WATERTOWN, Mass.--(BUSINESS WIRE)--May 24, 2006--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC - News), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the Friedman Billings Ramsey 2006 Growth Investor Conference to be held at the Grand Hyatt Hotel in New York, NY on May 31-June 1. Peyton J. Marshall, Panacos' Executive Vice President and Chief Financial Officer, will give a corporate overview at 11:15 a.m. on May 31.
